• News
  • Events
  • Contact us
  • Our websites
    • INVEST
    • INNOVATE
  • EN
  • DE
  • FR
Basel Area Business & Innovation
  • About us
  • Services
    • Invest in Basel Area
    • Innovate and accelerate
    • Switzerland Innovation Park
  • Team
  • Partners
  • Success stories
  • Publications
  • Media
  • Careers
Basel Area Business & Innovation

Both Basel cantons are first class borrowers

Standard & Poor’s has awarded the canton of Basel-City its top rating of AAA. The…
martin
martin11.09.2020

ChemAxon establishes subsidiary in Basel

ChemAxon develops software for application in the chemicals and biopharma industries. Now, the Hungarian company…
martin
martin11.06.2020

DSM strengthens the Basel Area life sciences cluster

The global nutrition and health corporation Royal DSM is establishing a new innovation center at…
martin
martin11.05.2020

Canton of Jura looking towards robotics

The canton of Jura has for quite some time been a hub for the precision…
martin
martin11.03.2020

Novartis agrees cooperation to fight Covid-19

A collaboration between Molecular Partners and Novartis has been announced. Molecular Partners will be responsible…
martin
martin10.29.2020

VectivBio secures investments totaling 110 million dollars

The Basel-based biotechnology firm VectivBio has received a capital injection of 110 million US dollars…
martin
martin10.19.2020

Polyphor receives up to 18 million dollars for development of antibiotics

The Allschwil-based company Polyphor has received a second funding award from the global consortium CARB-X…
martin
martin10.15.2020
Basel, Switzerland (Basel Area Business & Innovation)

What makes Switzerland’s economy resilient in face of COVID pandemic

The COVID-19 pandemic has hit economies worldwide – and we have not yet overcome it.…
annett
annett10.15.2020

Matériaux Sabag printing concrete elements

The Jura-based company Matériaux Sabag is now using a 3D printing solution to produce its…
martin
martin10.01.2020

Monte Rosa Therapeutics banks 96 million US dollars

The Basel-based biotechnology firm Monte Rosa Therapeutics has raised a total of 96 million US…
martin
martin09.28.2020
Previous 1 2 3 4 … 11 Next

Contact us

Basel Area Business & Innovation Dufourstrasse 11, 4010 Basel, Switzerland
info@baselarea.swiss
+41 61 295 50 00

Our websites

  • Invest
  • Innovate

Sign up for our newsletter

Subscribe

Receive our event invitations
Subscribe

Follow us

twitterlinkedinyou tube

© 2020 BaselArea | Terms & conditions | Privacy policy

  • About us
  • Services
    • Invest in Basel Area
    • Innovate and accelerate
    • Switzerland Innovation Park
  • Team
  • Partners
  • Success stories
  • Publications
  • Media
  • Careers
  • News
  • Events
  • Contact us
  • Our websites
    • INVEST
    • INNOVATE
  • EN
  • DE
  • FR
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Use of cookiesOK
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.